Müller Joachim, Aguado-Martínez Adriana, Balmer Vreni, Maly Dustin J, Fan Erkang, Ortega-Mora Luis-Miguel, Ojo Kayode K, Van Voorhis Wesley C, Hemphill Andrew
Institute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Department of Chemistry, University of Washington, Seattle, Washington, USA.
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02324-16. Print 2017 Apr.
We present the effects of two novel bumped kinase inhibitors, BKI-1517 and BKI-1553, against tachyzoites and in experimentally infected pregnant mice. These compounds inhibited tachyzoite proliferation of a transgenic beta-galactosidase reporter strain cultured in human foreskin fibroblasts with 50% inhibitory concentrations (ICs) of 0.05 ± 0.03 and 0.18 ± 0.03 μM, respectively. As assessed by an alamarBlue assay, fibroblast ICs were above 20 μM; however, morphological changes occurred in cultures treated with >5 μM BKI-1517 after prolonged exposure (>6 days). Treatment of intracellular tachyzoites with 5 μM BKI-1553 for 6 days inhibited endodyogeny by interfering with the separation of newly formed zoites from a larger multinucleated parasite mass. In contrast, parasites treated with 5 μM BKI-1517 did not form large complexes and showed much more evidence of cell death. However, after a treatment duration of 10 days , both compounds failed to completely prevent the regrowth of parasites from culture. BALB/c mice experimentally infected with Spain7 (Nc-Spain7) and then treated during 6 days with BKI-1517 or BKI-1553 at different dosages showed a significant reduction of the cerebral parasite load. However, fertility was impaired by BKI-1517 when applied at 50 mg/kg of body weight/day. At 20 mg/kg/day, BKI-1517 significantly inhibited the vertical transmission of to pups and increased the rate of survival of offspring. BKI-1553 was less detrimental to fertility and also provided significant but clearly less pronounced protection of dams and offspring. These results demonstrate that, when judiciously applied, this compound class protects offspring from vertical transmission and disease.
我们展示了两种新型的碰撞激酶抑制剂BKI-1517和BKI-1553对速殖子以及对实验性感染的怀孕小鼠的影响。这些化合物抑制了在人包皮成纤维细胞中培养的转基因β-半乳糖苷酶报告菌株的速殖子增殖,其50%抑制浓度(IC)分别为0.05±0.03和0.18±0.03μM。通过alamarBlue检测评估,成纤维细胞的IC高于20μM;然而,长时间暴露(>6天)后,用>5μM BKI-1517处理的培养物中出现了形态变化。用5μM BKI-1553处理细胞内速殖子6天,通过干扰新形成的子体从较大的多核寄生虫团块中的分离来抑制内二分裂生殖。相比之下,用5μM BKI-1517处理的寄生虫没有形成大的复合体,并且显示出更多细胞死亡的迹象。然而,处理10天后,两种化合物都未能完全阻止培养物中寄生虫的再生长。用Spain7(Nc-Spain7)实验感染的BALB/c小鼠,然后用不同剂量的BKI-1517或BKI-1553处理6天,脑内寄生虫负荷显著降低。然而,当以50mg/kg体重/天的剂量应用时,BKI-1517损害了生育能力。以20mg/kg/天的剂量,BKI-1517显著抑制了向幼崽的垂直传播并提高了后代的存活率。BKI-1553对生育能力的损害较小,并且也为母鼠和后代提供了显著但明显较弱的保护。这些结果表明,如果谨慎应用,这类化合物可保护后代免受垂直传播和疾病的影响。